Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Palma (São Paulo, Brazil), A. Cereta (São Paulo, Brazil), G. Matias (São Paulo, Brazil), P. Fratini (São Paulo, Brazil), L. Guimarães (Sâo Paulo, Brazil), L. Oliveira (Anapolis, Brazil), R. Farre (Barcelona, Spain), M. Miglino (Sâo Paulo, Brazil). Equine decellularized lung: a potencial approche for regenerative medicine. 588

Member's Comments

No comment yet.

Related content which might interest you: Médecine personnalisée et BPCO: où en sommes-nous ?Personalised medicine and COPD: where are we now? Source: International Congress 2016 – ERS/French Programme I Year: 2016 Pneumopathies infiltrantes diffuses sous immunothérapie / Interstitial lung diseases and immunotherapy Source: Virtual Congress 2021 – French programme 2021 Year: 2021 Mucoviscidose: enfin des traitements ciblés / Cystic fibrosis: targeted therapies, at last ! Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Interstitial lung disease: are we missing formes frustes of connective tissue disease? Source: Eur Respir J 2006; 28: 893-896 Year: 2006 Does emphysema influence the application of du Bois score in idiopathic pulmonary fibrosis? Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Microbiote et cancer bronchique: l'exemple de l'immunothérapie / Microbiota and lung cancer: an example of immunotherapy Source: Virtual Congress 2021 – French programme 2021 Year: 2021 YI03 - Lung tissue engineering: generation and characterization of decellularized lung scaffolds for stem cell differentiation Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Prise en charge de l’emphysème : Approche personnalisée / Management of emphysema: personalised approach Source: Virtual Congress 2021 – French programme 2021 Year: 2021 LSC 2012 abstract – Lung tissue engineering: generation and characterization of decellularized lung scaffolds for stem cell differentiation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Personalised medicine in interstitial lung diseases Source: Eur Respir Rev, 27 (148) 170117; 10.1183/16000617.0117-2017 Year: 2018 Lung tissue bioengineering for transplantation and modelling of development, disease and regeneration Source: Eur Respir Monogr 2021; 91: 248-272 Year: 2021 Troubles respiratoires du sommeil et cancer : données épidémiologiques / Respiratory disorders associated with sleep and cancer: epidemiological data Source: Virtual Congress 2020 – French programme 2020: Part I Year: 2020 Malignancies in lung transplant recipients: un update of the portuguese experience Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Personalised medicine for cystic fibrosis: treating the basic defect Source: Eur Respir Rev 2013; 22: 3-5 Year: 2013 Use of decellularized tracheas for airways engineering Source: International Congress 2016 – Current challenges in thoracic surgery Year: 2016 Advanced cell culture techniques and personalised medicine for cystic fibrosis Source: International Congress 2015 – Respiratory research in the Netherlands Year: 2015 Plethysmographic profil of patients with infiltrative lung diseases Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 La diffusion pulmonaire du monoxyde d’azote (DLNO): des recommandations pratiques aux applications cliniquesLung transfer of Nitric Oxide (DLNO): from practical guidelines to clinical applications Source: International Congress 2016 – ERS/French Programme II Year: 2016